Molecular imaging | p. 5 |
Peptide receptor imaging | p. 29 |
Radioimmunoscintigraphy | p. 39 |
Monitoring treatment | p. 57 |
Principles of radionuclide therapy | p. 79 |
The imaging of infection and inflammation | p. 93 |
Pediatric imaging | p. 107 |
Sentinel lymph node imaging in clinical nuclear medicine | p. 121 |
Functional imaging of cardiac disease | p. 145 |
Functional imaging of coronary artery and congenital heart disease | p. 147 |
Left ventricular dysfunction | p. 183 |
Radionuclide imaging in thoracic disease | p. 195 |
Ventilation perfusion imaging : a changing role for suspected pulmonary embolism | p. 197 |
Lung cancer | p. 223 |
Other pulmonary applications | p. 239 |
Renal radionuclide studies | p. 251 |
Anatomy, physiology, and tracer handling | p. 253 |
Non-imaging radionuclide assessment of renal function | p. 269 |
Vesico-ureteric reflux and urinary tract infection | p. 281 |
Hypertension | p. 297 |
Obstruction of the outflow tract | p. 305 |
Renal transplantation | p. 315 |
Renal tumors | p. 321 |
Skeletal physiology and anatomy applied to nuclear medicine | p. 331 |
Skeletal malignancy | p. 337 |
Metabolic bone disease | p. 355 |
Trauma and sports injuries | p. 363 |
Radionuclide evaluation of the failed joint replacement | p. 381 |
Rheumatology and avascular necrosis | p. 393 |
Pediatric indications | p. 403 |
Dementia | p. 415 |
Functional imaging in cerebrovascular disease and neuropsychiatry | p. 425 |
Epilepsy | p. 435 |
Neuro-oncology | p. 445 |
PET and SPECT imaging in movement disorders | p. 457 |
Head and neck cancer | p. 467 |
Salivary pathology | p. 483 |
Lachrymal studies | p. 485 |
Thyroid | p. 491 |
Parathyroid localization | p. 511 |
The adrenal gland | p. 521 |
Breast cancer | p. 543 |
Breast disease : single photon and positron emission tomography | p. 559 |
Testicular tumors | p. 569 |
Impotence | p. 575 |
Infertility | p. 585 |
Testicular perfusion imaging | p. 593 |
Gynecological cancer | p. 601 |
Prostate cancer | p. 609 |
Gastrointestinal bleeding | p. 621 |
Inflammatory bowel disease | p. 629 |
Functional studies of the gastrointestinal tract | p. 637 |
Positron emission tomography in gastrointestinal cancers | p. 645 |
Gastrointestinal neuroendocrine tumors | p. 653 |
Hepatobiliary disease : primary and metastatic liver tumors | p. 661 |
Anemia and polycythemia | p. 675 |
Imaging the spleen | p. 685 |
Imaging of lymphomas | p. 695 |
Lymphoscintigraphy | p. 715 |
Thyroid disease | p. 727 |
Endocrine : peptides | p. 745 |
Neuroblastoma | p. 755 |
The skeleton | p. 765 |
The use of [superscript 22]P | p. 773 |
The role of dosimetry | p. 781 |
Pitfalls and artifacts in [superscript 16]F-FDG PET and PET/CT imaging | p. 791 |
Diagnostic accuracy and cost-effectiveness issues | p. 799 |
Introduction | p. 815 |
Interactions and reactions | p. 821 |
New single-photon radiopharmaceuticals | p. 831 |
New radiopharmaceuticals for positron emission tomography | p. 839 |
Solid state and other detectors | p. 849 |
Image registration | p. 861 |
Attenuation correction in positron emission tomography and single photon emission computed tomography | p. 869 |
Table of Contents provided by Blackwell. All Rights Reserved. |
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.